Global Drug of Abuse (DOA) Testing Consumables Sales Market Report 2021

1 Drug of Abuse (DOA) Testing Consumables Market Overview

• 1.1 Drug of Abuse (DOA) Testing Consumables Product Scope
• 1.2 Drug of Abuse (DOA) Testing Consumables Segment by Type
  • 1.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Rapid Test Kits
  • 1.2.3 Assay Kits and Reagents
  • 1.2.4 Others
• 1.3 Drug of Abuse (DOA) Testing Consumables Segment by Application
  • 1.3.1 Global Drug of Abuse (DOA) Testing Consumables Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospitals
  • 1.3.3 Laboratories
  • 1.3.4 Workplace
  • 1.3.5 At-Home
  • 1.3.6 Others
• 1.4 Drug of Abuse (DOA) Testing Consumables Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Drug of Abuse (DOA) Testing Consumables Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Drug of Abuse (DOA) Testing Consumables Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Drug of Abuse (DOA) Testing Consumables Price Trends (2016-2027)

2 Drug of Abuse (DOA) Testing Consumables Estimates and Forecasts by Region

• 2.1 Global Drug of Abuse (DOA) Testing Consumables Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Drug of Abuse (DOA) Testing Consumables Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2016-2021)
• 2.3 Global Drug of Abuse (DOA) Testing Consumables Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Drug of Abuse (DOA) Testing Consumables Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)
  • 2.4.2 Europe Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)
  • 2.4.3 China Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)
  • 2.4.4 Japan Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)
  • 2.4.6 India Drug of Abuse (DOA) Testing Consumables Estimates and Projections (2016-2027)

3 Global Drug of Abuse (DOA) Testing Consumables Competition Landscape by Players

• 3.1 Global Top Drug of Abuse (DOA) Testing Consumables Players by Sales (2016-2021)
• 3.2 Global Top Drug of Abuse (DOA) Testing Consumables Players by Revenue (2016-2021)
• 3.3 Global Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2020)
• 3.4 Global Drug of Abuse (DOA) Testing Consumables Average Price by Company (2016-2021)
• 3.5 Manufacturers Drug of Abuse (DOA) Testing Consumables Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Drug of Abuse (DOA) Testing Consumables Market Size by Type

• 4.1 Global Drug of Abuse (DOA) Testing Consumables Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Drug of Abuse (DOA) Testing Consumables Price by Type (2016-2021)
• 4.2 Global Drug of Abuse (DOA) Testing Consumables Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Type (2022-2027)

5 Global Drug of Abuse (DOA) Testing Consumables Market Size by Application

• 5.1 Global Drug of Abuse (DOA) Testing Consumables Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Drug of Abuse (DOA) Testing Consumables Price by Application (2016-2021)
• 5.2 Global Drug of Abuse (DOA) Testing Consumables Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Application (2022-2027)

6 North America Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 6.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 6.1.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 6.1.2 North America Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 6.2 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 6.2.1 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 6.3 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 6.3.1 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application (2022-2027)

7 Europe Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 7.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 7.1.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 7.1.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 7.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 7.2.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 7.3 Europe Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 7.3.1 Europe 122 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 122 Sales Breakdown by Application (2022-2027)

8 China Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 8.1 China Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 8.1.1 China Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 8.1.2 China Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 8.2 China Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 8.2.1 China Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 8.3 China Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 8.3.1 China 144 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 9.1 Japan Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 9.1.1 Japan Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 9.1.2 Japan Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 9.2 Japan Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 9.2.1 Japan Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 9.3 Japan Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 10.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 10.1.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 10.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 10.2.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Drug of Abuse (DOA) Testing Consumables Market Facts & Figures

• 11.1 India Drug of Abuse (DOA) Testing Consumables Sales by Company
  • 11.1.1 India Drug of Abuse (DOA) Testing Consumables Sales by Company (2016-2021)
  • 11.1.2 India Drug of Abuse (DOA) Testing Consumables Revenue by Company (2016-2021)
• 11.2 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type
  • 11.2.1 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Type (2022-2027)
• 11.3 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application
  • 11.3.1 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Drug of Abuse (DOA) Testing Consumables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Drug of Abuse (DOA) Testing Consumables Business

• 12.1 Siemens AG
  • 12.1.1 Siemens AG Corporation Information
  • 12.1.2 Siemens AG Business Overview
  • 12.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Siemens AG Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.1.5 Siemens AG Recent Development
• 12.2 Merck
  • 12.2.1 Merck Corporation Information
  • 12.2.2 Merck Business Overview
  • 12.2.3 Merck Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Merck Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.2.5 Merck Recent Development
• 12.3 Roche
  • 12.3.1 Roche Corporation Information
  • 12.3.2 Roche Business Overview
  • 12.3.3 Roche Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Roche Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.3.5 Roche Recent Development
• 12.4 Thermo Fisher Scientific
  • 12.4.1 Thermo Fisher Scientific Corporation Information
  • 12.4.2 Thermo Fisher Scientific Business Overview
  • 12.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.4.5 Thermo Fisher Scientific Recent Development
• 12.5 Bio-Rad
  • 12.5.1 Bio-Rad Corporation Information
  • 12.5.2 Bio-Rad Business Overview
  • 12.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Bio-Rad Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.5.5 Bio-Rad Recent Development
• 12.6 Abbott
  • 12.6.1 Abbott Corporation Information
  • 12.6.2 Abbott Business Overview
  • 12.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Abbott Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.6.5 Abbott Recent Development
• 12.7 Quest Diagnostics
  • 12.7.1 Quest Diagnostics Corporation Information
  • 12.7.2 Quest Diagnostics Business Overview
  • 12.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.7.5 Quest Diagnostics Recent Development
• 12.8 Psychemedics
  • 12.8.1 Psychemedics Corporation Information
  • 12.8.2 Psychemedics Business Overview
  • 12.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Psychemedics Drug of Abuse (DOA) Testing Consumables Products Offered
  • 12.8.5 Psychemedics Recent Development

13 Drug of Abuse (DOA) Testing Consumables Manufacturing Cost Analysis

• 13.1 Drug of Abuse (DOA) Testing Consumables Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
• 13.4 Drug of Abuse (DOA) Testing Consumables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Drug of Abuse (DOA) Testing Consumables Distributors List
• 14.3 Drug of Abuse (DOA) Testing Consumables Customers

15 Market Dynamics

• 15.1 Drug of Abuse (DOA) Testing Consumables Market Trends
• 15.2 Drug of Abuse (DOA) Testing Consumables Drivers
• 15.3 Drug of Abuse (DOA) Testing Consumables Market Challenges
• 15.4 Drug of Abuse (DOA) Testing Consumables Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List